CGChristoph A. Gebeshuber

Christoph A. Gebeshuber

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christoph A. Gebeshuber has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    miR‐29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis

    by Christoph A Gebeshuber, Kurt Zatloukal, Javier Martinez

    EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.


  • β-Catenin/LEF-1 Signalling in Breast Cancer – Central Players Activated by a Plethora of Inputs

    by Christoph A. Gebeshuber, Stefan Sladecek, Stefan Grunert

    Although the role of Wnt signalling in breast cancer is far from being fully understood, in the last years its importance has been reported frequently. Besides stimulation by canonical Wnt signalling, the downstream effectors β-catenin and the transcriptional modulators of the T-cell factor/lymphoid enhancer-binding factor (TCF/LEF) family can also be activated by other inputs including the TGF-β pathway. Wnt and TGF-β signalling are both major signal transduction pathways, which provide important cues during development and tumor progression. However, particularly TGF-β has a complicated influence on oncogenesis, which ranges from suppressive to promoting activity. Signalling pathways activated in parallel with TGF-β might determine the oncogenic influence, and therefore place signals cooperating with TGF-β into the limelight. During early development Wnt and TGF-β signalling collaborate extensively. Here we provide an overview of the known interactions of Wnt with TGF-β signalling in development and metastasis, particularly in breast cancer. We want to focus on the Wnt-activated transcription factor complex β-catenin/LEF-1, its upstream activators, its downstream targets and consequences on the cellular level in response to β-catenin/LEF-1 activation.